tiprankstipranks
Advertisement
Advertisement
Cell-Free DNA Platform Positioning Targets Scaling Needs in Cell and Gene Therapy
PremiumPrivate CompaniesCell-Free DNA Platform Positioning Targets Scaling Needs in Cell and Gene Therapy
1d ago
Touchlight Showcases Cell-Free DNA Platform and Cost Advantages at ASGCT
Premium
Private Companies
Touchlight Showcases Cell-Free DNA Platform and Cost Advantages at ASGCT
1d ago
Cell-Free DNA Platform Positioned as Alternative to Plasmid DNA in Gene Therapy Manufacturing
Premium
Private Companies
Cell-Free DNA Platform Positioned as Alternative to Plasmid DNA in Gene Therapy Manufacturing
1d ago
Touchlight – Weekly Recap
PremiumPrivate CompaniesTouchlight – Weekly Recap
4d ago
Touchlight Highlights Cell-Free DNA Platform for Gene and mRNA Therapy Manufacturing
Premium
Private Companies
Touchlight Highlights Cell-Free DNA Platform for Gene and mRNA Therapy Manufacturing
6d ago
Touchlight Highlights Cell-Free DNA Platform Ahead of ASGCT 2026
Premium
Private Companies
Touchlight Highlights Cell-Free DNA Platform Ahead of ASGCT 2026
6d ago
Touchlight Showcases Cell-Free DNA Platform at ASGCT 2026 to Target Gene and Cell Therapy Developers
PremiumPrivate CompaniesTouchlight Showcases Cell-Free DNA Platform at ASGCT 2026 to Target Gene and Cell Therapy Developers
8d ago
Touchlight Strengthens Board With Industry Veteran Appointment
Premium
Private Companies
Touchlight Strengthens Board With Industry Veteran Appointment
8d ago
Touchlight Targets Gene Therapy Developers With ASGCT 2026 Presence
Premium
Private Companies
Touchlight Targets Gene Therapy Developers With ASGCT 2026 Presence
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100